Nelson Advisors joins SoftBank Vision Fund, J.P. Morgan, IQVIA, Siemens Healthineers, Blackstone, Mayo Clinic, Cedars Sinai executives at the Capital Xchange Forum 2026

Nelson Advisors, a London-based M&A advisory firm focused on European HealthTech, MedTech, digital health and healthcare AI companies, typically with an enterprise value of $25M to $250M announces the firm’s participation in the Capital Xchange Forum 2026, part of the Global Health Exhibition in Riyadh, Saudi Arabia, in October 2026.

Day 1 is a panel on healthtech funding and M&A, comparing 2026 with 2025. It covers how investors are backing fewer but stronger companies, how AI and tech-enabled care are reshaping value, and what makes a company ready for a strategic exit. Nelson Advisors co-founder Lloyd Price speaks alongside Dr. Elena Lovo of J.P. Morgan and others.

Day 2 is an investor-led panel on where money is going: which technologies are moving into focus, how to tell durable opportunities from hype, and what evidence builds investor conviction. Speakers include Antony Kalindjian of SoftBank Vision Fund, Price and Lovo again, and representatives of TVM Capital and Panacea.

Source: https://www.globalhealthsaudi.com/congress/capitalxchangeforum/